Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01935856

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

A Dose Escalation, Single and Multiple Dose, Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Sponsor: Kyowa Kirin Co., Ltd.

Conditions Hyperparathyroidism

Interventions KHK7580

Updated 8 times since 2017 Last updated: Feb 28, 2017 Started: Aug 31, 2013 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Hyperparathyroidism, this trial is completed. The trial is conducted by Kyowa Kirin Co., Ltd. and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Aug 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Aug 2019 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Mar 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Mar 2017 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kyowa Kirin Co., Ltd.

Data source: Kyowa Kirin Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo, Japan